Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push December 26, 2023December 26, 2023
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion December 22, 2023December 22, 2023